BIODESIX INC
Public company- Headquarters
- LOUISVILLE, Colorado
- Ticker
- BDSX
- CIK
- 0001439725
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
0 appointments, 1 departure
Last event
Nov 5, 2026
Executive departureChief Commercial Officer departs: Kieran O’Kane
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Chief Commercial OfficerKieran O’Kane | Nov 5, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Guardant Health, Inc.
Class II director appointed: Kevin R. Sayer
- QUEST DIAGNOSTICS INC
Executive Vice President role change: Catherine T. Doherty
- Celcuity Inc.
director appointed: David W. Gryska
- Fortrea Holdings Inc.
Chief Accounting Officer appointed: Carrie Russell
- Executive departure
Chief Commercial Officer departs: Kieran O’Kane
Kieran O’Kane, Chief Commercial Officer of BIODESIX INC, departs the role, effective November 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Nov 5, 2026Role: Chief Commercial Officer
Only one public record so far. We add events as soon as a new filing lands; watch BIODESIX INC to get them in your digest.
Last verified Nov 9, 2026